
Great Wall Securities reviewed Adisseo's (600299) Q3 2025 report, showing first-three-quarter revenue up 13.67% to 12.931 billion yuan while net income fell 1.29%. Third-quarter profit dropped 36.77% amid raw material costs, tariffs and lower product prices.
The company's methionine capacity expansion is continuing.
Methionine supply growth from a major Chinese producer keeps amino acid supply ample, which limits upside in feed-grade methionine prices. Margin pressure from raw materials and tariffs may push producers to keep pricing competitive.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.